A rat model of studying tissue-type plasminogen activator thrombolysis in ischemic stroke with diabetes

Stroke

Volumn 43, Issue 2, 2012, Pages 567-570

  Fan, Xiang ^a   Qiu, Jianhua ^a   Yu, Zhanyang ^a   Dai, Haibin ^a   Singhal, Aneesh B ^a   Lo, Eng H ^a   Wang, Xiaoying ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

diabetes; rats; thrombolytics; tPA

Indexed keywords

GLUCOSE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBOLIC FOCAL STROKE; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REPERFUSION; STROKE; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; BRAIN EDEMA; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FIBRINOLYTIC AGENTS; IMMUNOHISTOCHEMISTRY; INTRACRANIAL EMBOLISM; LASER-DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; NERVOUS SYSTEM DISEASES; RATS; RATS, WISTAR; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84856454145     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.635250     Document Type: Article

References (16)

1. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study. Lancet. 2010;376:112-123.
2. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke. 2001;32:2426-2432. (Pubitemid 32954818)
3. Poppe AY, Majumdar SR, Jeerakathil T, Ghali W, Buchan AM, Hill MD. Canadian Alteplase for Stroke Effectiveness Study Investigators. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care. 2009;32:617-622.
4. Kruyt ND, Biessels GJ, Devries JH, Roos YB. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol. 2010;6:145-155.
5. Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, Lo EH. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke. 2004;35: 2726-2730. (Pubitemid 39458380)
6. Chen J, Cui X, Zacharek A, Cui Y, Roberts C, Chopp M. White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke. Stroke. 2011;42:445-452.
7. Nakae M, Kamiya H, Naruse K, Horio N, Ito Y, Mizubayashi R, et al. Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats. Diabetes. 2006;55:1470-1477. (Pubitemid 44195389)
8. Zhu H, Fan X, Yu Z, Liu J, Murata Y, Lu J, et al. Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke. J Cereb Blood Flow Metab. 2010;30:1137-1146.
9. Henninger N, Bouley J, Bråtane BT, Bastan B, Shea M, Fisher M. Laser Doppler flowmetry predicts occlusion but not tPA-mediated reperfusion success after rat embolic stroke. Exp Neurol. 2009;215:290-297.
10. Asahi M, Asahi K, Wang X, Lo EH. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 2000;20:452-457. (Pubitemid 30164888)
11. Strbian D, Karjalainen-Lindsberg ML, Tatlisumak T, Lindsberg PJ. Cerebral mast cells regulate early ischemic brain swelling and neutrophil accumulation. J Cereb Blood Flow Metab. 2006;26:605-612.
12. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17:472-476. (Pubitemid 16085691)
13. Zhang L, Zhang ZG, Zhang R, Morris D, Lu M, Coller BS, et al. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke. Circulation. 2003;107: 2837-2843. (Pubitemid 36705995)
14. Saguchi T, Onoue H, Urashima M, Ishibashi T, Abe T, Furuhata H. Effective and safe conditions of low-frequency transcranial ultrasonic thrombolysis for acute ischemic stroke: neurologic and histologic evaluation in a rat middle cerebral artery stroke model. Stroke. 2008;39: 1007-1011. (Pubitemid 351619560)
15. Riad A, Westermann D, Van Linthout S, Mohr Z, Uyulmaz S, Becher PM, et al. Enhancement of endothelial nitric oxide synthase production reverses vascular dysfunction and inflammation in the hindlimbs of a rat model of diabetes. Diabetologia. 2008;51:2325-2332.
16. Hagiwara H, Kaizu K, Uriu K, Noguchi T, Takagi I, Qie YL, et al. Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models. Thromb Res. 2003;111:301-309. (Pubitemid 38021951)